Purchase of a platform high throughput metagenomics sequencing system
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Food and Drug Administration is forecasting the purchase of an Aviti Element high throughput metagenomics sequencing system to be evaluated as a potential replacement for Illumina systems. This technology is intended to support the critical role of genomic food safety applications conducted by whole genome sequencing specialists. The procurement is currently entered as an unfunded zero dollar requisition. A review for funding and execution will take place in the summer of 2026, provided that the necessary funds become available.
General Info
Place of Performance
USASet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Prepare for this forecast
Research this forecast and prepare for the solicitation
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
